Assay Platform for Clinically Relevant Metallo-β-lactamases
Open Access
- 16 August 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (17), 6945-6953
- https://doi.org/10.1021/jm400769b
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Selective Penicillin-Binding Protein Imaging Probes Reveal Substructure in Bacterial Cell DivisionACS Chemical Biology, 2012
- Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitorProceedings of the National Academy of Sciences of the United States of America, 2012
- Carbapenems: Past, Present, and FutureAntimicrobial Agents and Chemotherapy, 2011
- Biochemical Characterization of Sfh-I, a Subclass B2 Metallo-β-Lactamase from Serratia fonticola UTAD54Antimicrobial Agents and Chemotherapy, 2011
- Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase InhibitorsJournal of Biological Chemistry, 2011
- NH-1,2,3-Triazole Inhibitors of the VIM-2 Metallo-β-LactamaseACS Medicinal Chemistry Letters, 2010
- Evolving Carbapenemases: Can Medicinal Chemists Advance One Step Ahead of the Coming Storm?Journal of Medicinal Chemistry, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand bindingNucleic Acids Research, 2009
- A versatile ligation-independent cloning method suitable for high-throughput expression screening applicationsNucleic Acids Research, 2007